Arabic Arabic English English French French German German

Carevive, COS Ink Partnership to Improve Cancer Care with RWE

What You Should Know:

Carevive and Clinical Outcome Solutions (COS) announced a new partnership to improve the cancer patient experience using RWE and RWD. The partnership will leverage Carevive’s innovative digital oncology platform to capture the patient experience, and COS’ deep experience in analyzing data, ultimately providing valuable insights for life science companies and regulators alike.

– The Carevive platform PROmpt enables cancer care teams to monitor and manage their patients remotely, which improves survival outcomes and patient quality of life. The platform also enables large-scale digital data collection via the Oncology Pragmatic Trial Investigator Network (Carevive OPT-IN®), merging electronic medical records (EMR) with patient reported outcomes (PRO) to offer cancer centers a holistic, longitudinal view of their patient population for quality improvement and pathway enhancement purposes.

– COS is a global leader in delivering innovative science to capture and communicate the patient voice, in order to provide actionable evidence through qualitative and quantitative research, with a specific focus on Clinical Outcomes Assessments in the oncology space.  Through the partnership, COS will apply this expertise to providing data analytic support to generate insights from these novel patient experience datasets.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Taif: Over 12,000 Beneficiaries Served by Specialist Dental Center in 3 Months

Next Post

COVID-19 Brief: Atea Initiates Phase III for Investigational Antiviral, BioNTech Tests Vaccine in Infants

Related Posts